Investigators presented 12-month phase 2 data on subretinal OCU410 gene therapy in patients with geographic atrophy.

European Affiliate, based in Amsterdam, to support upcoming marketing authorization submissions, OCU410 Phase 3 development ...

Ocugen appoints Jolanda Crombach as General Manager of its European affiliate to advance gene therapy programs for blindness diseases.

A candidate-gene study of Chinese Han children finds nominal links between complement-related gene variants and severe ...

While looking at the characters in 'Romancing SaGa 2', there was something that had always felt a bit strange to me. Why are ...

"I must make sure not to make a single mistake with honorifics during my presentation." If you have experience having your ...

Diablo V has a rare opportunity to learn from everything that came before it, both within the series and outside it. Here is what I want Blizzard to keep, rethink and completely overhaul for the next ...

With big cities, iconic small towns, picturesque mountains and a prime spot along the Atlantic Ocean, Georgia is one of the most diverse vacation destinations in the South. To help you decide which ...

Smyrna police are asking for the public's help to identify a person seen with a murder suspect before and after a deadly summer shooting. Smyrna police are asking for the public's help to identify a ...

Background Type 2 diabetes is a pandemic following an exponential rise in the number of cases. Current trends indicate that younger individuals have a threefold increased risk for diabetes in ...

(Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology company developing gene therapies for blindness diseases, today announced that the Company will present on its innovative modifier ...